{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.139G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "139"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        },
        {
          "HGVS": "NM_000345.4:c.89A>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "C",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_000345.4:c.158G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005364"
  },
  "Experiment Method": [
    {
      "Assay Method": "Thioflavin S binding",
      "Material used": {
        "Material Source": "Recombinant Peptide",
        "Material Name": "α-synuclein",
        "Description": "αS solutions were prepared from Recombinant Peptide Technologies (LLC, GA, USA) and stored at −80 °C."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.139G>A",
          "Conclusion": "Accelerated",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K mutation accelerates fibril formation and oligomerization."
        },
        {
          "Variant": "NM_000345.4:c.89A>C",
          "Conclusion": "Decelerated",
          "Molecular Effect": "loss-of-function",
          "Result Description": "A30P mutation decelerates fibril formation and oligomerization."
        },
        {
          "Variant": "NM_000345.4:c.158G>C",
          "Conclusion": "Accelerated",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mutation accelerates fibril formation and oligomerization."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each figure comprises data obtained with 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "WT αS was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Data were analyzed using fluorescence intensity measurements and circular dichroism spectroscopy."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Circular Dichroism Spectroscopy (CD)",
      "Material used": {
        "Material Source": "Recombinant Peptide",
        "Material Name": "α-synuclein",
        "Description": "αS solutions were prepared from Recombinant Peptide Technologies (LLC, GA, USA) and stored at −80 °C."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.139G>A",
          "Conclusion": "Accelerated",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K mutation accelerates the secondary structure change and oligomerization."
        },
        {
          "Variant": "NM_000345.4:c.89A>C",
          "Conclusion": "Decelerated",
          "Molecular Effect": "loss-of-function",
          "Result Description": "A30P mutation decelerates the secondary structure change and oligomerization."
        },
        {
          "Variant": "NM_000345.4:c.158G>C",
          "Conclusion": "Accelerated",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mutation accelerates the secondary structure change and oligomerization."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each figure comprises data obtained with 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "WT αS was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Data were analyzed using molar ellipticity measurements."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Photo-induced Cross-linking of Unmodified Proteins (PICUP)",
      "Material used": {
        "Material Source": "Recombinant Peptide",
        "Material Name": "α-synuclein",
        "Description": "αS solutions were prepared from Recombinant Peptide Technologies (LLC, GA, USA) and stored at −80 °C."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.139G>A",
          "Conclusion": "Increased oligomer size",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K mutation produced larger oligomeric assemblies."
        },
        {
          "Variant": "NM_000345.4:c.89A>C",
          "Conclusion": "Decreased oligomer size",
          "Molecular Effect": "loss-of-function",
          "Result Description": "A30P mutation produced smaller oligomeric assemblies."
        },
        {
          "Variant": "NM_000345.4:c.158G>C",
          "Conclusion": "Increased oligomer size",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mutation produced larger oligomeric assemblies."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each figure comprises data obtained with 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "WT αS was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Data were analyzed using SDS-PAGE and silver staining."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Electron Microscopy (EM)",
      "Material used": {
        "Material Source": "Recombinant Peptide",
        "Material Name": "α-synuclein",
        "Description": "αS solutions were prepared from Recombinant Peptide Technologies (LLC, GA, USA) and stored at −80 °C."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.139G>A",
          "Conclusion": "Accelerated",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K mutation accelerated the formation of fibrils."
        },
        {
          "Variant": "NM_000345.4:c.89A>C",
          "Conclusion": "Decelerated",
          "Molecular Effect": "loss-of-function",
          "Result Description": "A30P mutation decelerated the formation of fibrils."
        },
        {
          "Variant": "NM_000345.4:c.158G>C",
          "Conclusion": "Accelerated",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mutation accelerated the formation of fibrils."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each figure comprises data obtained with 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "WT αS was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Data were analyzed using EM images."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Atomic Force Microscopy (AFM)",
      "Material used": {
        "Material Source": "Recombinant Peptide",
        "Material Name": "α-synuclein",
        "Description": "αS solutions were prepared from Recombinant Peptide Technologies (LLC, GA, USA) and stored at −80 °C."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.139G>A",
          "Conclusion": "Increased oligomer size",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K mutation produced larger oligomeric assemblies."
        },
        {
          "Variant": "NM_000345.4:c.89A>C",
          "Conclusion": "Decreased oligomer size",
          "Molecular Effect": "loss-of-function",
          "Result Description": "A30P mutation produced smaller oligomeric assemblies."
        },
        {
          "Variant": "NM_000345.4:c.158G>C",
          "Conclusion": "Increased oligomer size",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T mutation produced larger oligomeric assemblies."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each figure comprises data obtained with 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "WT αS was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Data were analyzed using AFM images."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}